The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

Press releases published on September 10, 2026

Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Magnite and ITN Expand Partnership to Introduce Agentic AI Solution for Local Linear TV
Commerce Announces Strategic Operating Plan to Accelerate Profitability and Free Cash Flow Generation
Teads Expands Global CTV Offering with Whale TV Partnership
Glassbox Earns Solutions Partner With Certified Software Designation for Financial Services AI Within the Microsoft AI Cloud Partner Program
Zero RFI and PRIVV Partner to Bring AI Project Intelligence to Building Owners
SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer
Ionic Digital Receives Base Load Provisional Classification in ERCOT’s Batch Zero Process
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
Xtract One Technologies to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15–16, 2026
Erasca Announces Multiple Presentations at the Upcoming 38th EORTC-NCI-AACR Symposium
BWT Alpine Formula One Team and SEALSQ advance Formula One’s First Quantum Security Partnership with Hybrid Quantum-Classical Simulation
electroCore to Participate at H.C. Wainwright Global Investment Conference
Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting
Rezolve Ai to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Scientist Home Future Health Trial Demonstrates Significant Reduction in Eczema Symptoms using Evidence-based Nutritional Therapy
Percona and Coroot Partner to Bring Full-Stack Observability to Open Source Database Environments
Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth
CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The California STEM Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.